Yukinobu Ikeya

Dr. Yukinobu Ikeya

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2017 in Journal of Natural Medicines
Verified
Journal Article
Closed access
PDF file
AFAiri Fujii
Airi Fujii
TOTetsuya Okuyama
Tetsuya Okuyama
KWKoji Wakame
Koji Wakame
TOTadayoshi Okumura
Tadayoshi Okumura
YIYukinobu Ikeya
Yukinobu Ikeya
MNMikio Nishizawa
Mikio Nishizawa

3 July 2019 in Journal of Natural Medicines
Verified
Journal Article
Open access
PDF file
TIToshinari Ishii
Toshinari Ishii
TOTetsuya Okuyama
Tetsuya Okuyama
NNNao Noguchi
Nao Noguchi
YNYuto Nishidono
Yuto Nishidono
TOTadayoshi Okumura
Tadayoshi Okumura
MNMikio Nishizawa
Mikio Nishizawa
The crude drug Sojutsu, as defined by the Japanese Pharmacopoeia, is the rhizome of Atractylodes lancea De Candolle, Atractylodes chinensis Koidzumi, or their interspecific hybrids (Asteraceae). Sojutsu is one of the traditional Kampo formulas, which are administered to patients suffering from stomach disorders, edema, and nephrotic syndrome. Although antiinflammatory effects of Sojutsu have been reported, its effects on the liver and kidney have not been extensively investigated. Here, we used a Sojutsu sample identified as A. chinensis rhizome and isolated several constituents from its ethyl acetate (EtOAc)-soluble fraction that decreased production of the proinflammatory mediator nitric oxide (NO) in interleukin 1β-treated rat hepatocytes. Among the constituents in this fraction, atractylodin showed the highest activity to suppress NO production, whereas hinesol, β-eudesmol, and α-bisabolol showed low activity. Atractylodin decreased the levels of inducible nitric oxide synthase, tumor necrosis factor α, and lipocalin 2 messenger RNAs (mRNAs). The EtOAc-soluble fraction of the A. chinensis rhizome extract was administered daily for 20 weeks to high immunoglobulin A (HIGA) mice, whose pathological findings resemble human immunoglobulin A nephropathy. This fraction decreased the weight of white adipose tissue and decreased mesangial proliferation and immunoglobulin A deposition in glomeruli. These results indicate that the EtOAc-soluble fraction, which included antiinflammatory constituents, may be responsible for improvement of the mesangial lesions in HIGA mice.

22 November 2018 in Journal of Natural Medicines
Verified
Journal Article
Closed access
PDF file
YYYuko Yamauchi
Yuko Yamauchi
TOTetsuya Okuyama
Tetsuya Okuyama
TIToshinari Ishii
Toshinari Ishii
TOTadayoshi Okumura
Tadayoshi Okumura
YIYukinobu Ikeya
Yukinobu Ikeya
MNMikio Nishizawa
Mikio Nishizawa

1 January 2012 in HOAJ Biology
Verified
Journal Article
Open access
PDF file
NONaomi Ohno
Naomi Ohno
EYEmi Yoshigai
Emi Yoshigai
TOTetsuya Okuyama
Tetsuya Okuyama
YYYuka Yamamoto
Yuka Yamamoto
TOTadayoshi Okumura
Tadayoshi Okumura
MNMikio Nishizawa
Mikio Nishizawa
Background: Flos Lonicerae japonicae (FLJ; Kinginka) is the dried flowers and buds of the Japanese honeysuckle Lonicera japonica Thunberg. FLJ has been used as a Japanese Kampo medicine to treat

11 October 2011 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
TMTakashi Matsuura
Takashi Matsuura
Masaki KaiboriMasaki Kaibori
Masaki Kaibori
YAYoshiro Araki
Yoshiro Araki
MMMiho Matsumiya
Miho Matsumiya
YYYuka Yamamoto
Yuka Yamamoto
AKA‐Hon Kwon
A‐Hon Kwon

1 December 2020 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
FNFebby Nurdiya Ningsih
Febby Nurdiya Ningsih
TOTetsuya Okuyama
Tetsuya Okuyama
STShoko To
Shoko To
YNYuto Nishidono
Yuto Nishidono
TOTadayoshi Okumura
Tadayoshi Okumura
MNMikio Nishizawa
Mikio Nishizawa
The rhizome of Cnidium officinale (Umbelliferae) (known as Senkyu in Japan; COR) has been used as a crude drug in Japanese Kampo formulas, such as Jumihaidokuto (to treat eczema and urticaria) and Kakkontokasenkyushin’i (to treat rhinitis). COR contains phthalides, which are thought to be potent principal constituents. Few studies have been reported about the comparison of anti-inflammatory activity of COR constituents. We aimed to identify the constituents in COR and compare their anti-inflammatory activity. COR was extracted with methanol and fractionated into ethyl acetate (EtOAc)-soluble, n-butanol-soluble, and water-soluble fractions. Primary cultured rat hepatocytes were used to assess anti-inflammatory activity by monitoring the interleukin (IL)-1β-induced production of nitric oxide (NO), an inflammatory mediator. The EtOAc-soluble fraction significantly suppressed NO production without showing cytotoxicity in IL-1β-treated hepatocytes, whereas the n-butanol-soluble fraction showed less potency, and the water-soluble fraction did not significantly affect the NO levels. Four constituents were isolated from the EtOAc-soluble fraction and identified as senkyunolide A, (3S)-butylphthalide, neocnidilide, and cnidilide. Among these phthalides and (Z)-ligustilide, senkyunolide A and (Z)-ligustilide efficiently suppressed NO production in hepatocytes, whereas the others showed less potency in the suppression of NO production. Furthermore, senkyunolide A decreased the levels of the inducible nitric oxide synthase (iNOS) protein and mRNA, as well as the levels of mRNAs encoding proinflammatory cytokines (e.g., tumor necrosis factor α) and chemokine C–C motif ligand 20. These results suggest that senkyunolide A may cause the anti-inflammatory and hepatoprotective effects of COR by suppressing the genes involved in inflammation.